Skip to main content
# Title Department Research Year
21 Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors. Department of Pharmaceutical Organic Chemistry 2024
22 Zirconium-based hydrophobic-MOFs as innovative electrode modifiers for flibanserin determination: Exploring the electrooxidation mechanism using a comprehensive spectroelectrochemical study Department of Pharmaceutical Analytical Chemistry 2024
23 Computational Design of Azine-Linked Hybrids of 2-Indolinone-Thiazolodine Scaffold as Novel and Promising Quorum Sensing Inhibitors Department of Medicinal Chemistry 2024
24 Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit incidence, types, and acceptability Department of Clinical Pharmacy 2024
25 Thunbergiside A: An unprecedented neolignan isolated from Gardenia thunbergia L. f. and the antifungal activity of selected phytochemicals Department of Pharmacognosy 2024
26 Development of an innovative turn-on fluorescent probe for targeted in-vivo detection of nitric oxide in rat brain extracts as a biomarker for migraine disease Department of Pharmaceutical Analytical Chemistry 2024
27 A dual emissive silver-riboflavin complex and nitrogen-doped carbon dot nanoprobe for ratiometric detection of glutathione Department of Pharmaceutical Analytical Chemistry 2024
28 Phenotypic detection of ESBL and MBL producing Klebsiella pneumoniae in critically ill patients with nosocomial pneumonia Department of Microbiology and Immunology 2024
29 Sertaconazole-PLGA nanoparticles for management of ocular keratitis Department of Pharmaceutics 2024
30 Selective fluorescence turn-on detection of combination cisplatin–etoposide chemotherapy based on N-CDs/GSH-CuNCs nanoprobe† Department of Pharmaceutical Analytical Chemistry 2023